C07D 491/056
With two or more oxygen atoms as ring hetero atoms in the
Official title: with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
C07D491/056 (With two or more oxygen atoms as ring hetero atoms in the) appears on 416 US grants and 683 published applications in this corpus.
Search patents in C07D- Granted patents
- 416
- Published applications
- 683
- Assignees
- 364
- Inventors
- 2,266
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 2 |
| 2006 | 0 | 3 |
| 2007 | 0 | 8 |
| 2008 | 0 | 7 |
| 2009 | 2 | 10 |
| 2010 | 3 | 23 |
| 2011 | 9 | 24 |
| 2012 | 8 | 24 |
| 2013 | 23 | 37 |
| 2014 | 31 | 51 |
| 2015 | 39 | 33 |
| 2016 | 28 | 49 |
| 2017 | 42 | 27 |
| 2018 | 28 | 45 |
| 2019 | 37 | 33 |
| 2020 | 33 | 40 |
| 2021 | 24 | 41 |
| 2022 | 27 | 41 |
| 2023 | 20 | 59 |
| 2024 | 21 | 44 |
| 2025 | 26 | 38 |
| 2026 | 12 | 44 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Solid forms of 3-(5-Fluorobenzofuran-3-yl)-4-(5-methyl-5H-[1,3]dioxolo[4,5-f]indol-7-yl)pyrrole-2,5-dione22 Sep 2026US 12,741,973 B2Actuate Therapeutics Inc.
- Inhibition of glial cell activation7 Jul 2026US 12,673,957 B2Lapko Inc
- Method of inhibiting tau phosphorylation7 Jul 2026US 12,674,134 B2Filana Therapeutics, Inc.
- Method of inhibiting tau phosphorylation23 Jun 2026US 12,662,658 B2Filana Therapeutics, Inc.
- Oxynitidine derivatives useful as inhibitors of topoisomerase IB (TOP1) and tyrosyl-DNA phosphodiesterase 1 (TDP1)16 Jun 2026US 12,655,107 B2Shenzhen Xuhua Biotech Co. Ltd.
- Oxazole trpml1 agonists and uses thereof1 Oct 2026US 2026/0297104 A1Libra Therapeutics, Inc.
- Amorphous form of isoquinoline derivative17 Sep 2026US 2026/0274855 A1vTv Therapeutics LLC
- Isoindoline compositions and methods for treating neurodegenerative disease3 Sep 2026US 2026/0257994 A1Cognition Therapeutics, Inc.
- Imine compounds as well as preparation method therefor and use thereof27 Aug 2026US 2026/0248763 A1Bio Genuine (Shanghai) Biotech Co., Ltd
- Bicyclic heterocyclic amide inhibitors of nav1.8 for the treatment of pain20 Aug 2026US 2026/0242356 A1
Most cited
By later US patents
- Lipids and compositions for the delivery of therapeutics102US 8,999,351 B2Tekmira Pharmaceuticals Corporation · 2015
- Lipids and compositions for the delivery of therapeutics101US 9,186,325 B2Tekmira Pharmaceuticals Corporation · 2015
- Compounds including substituted thienopyrimidinone derivatives as ligands for modulating chemosensory receptors54US 7,928,111 B2Senomyx, Inc. · 2011
- Subunit selective NMDA receptor potentiators for the treatment of neurological conditions45US 8,822,462 B2Emory University · 2014
- DNA-PK inhibitors44US 9,376,448 B2Vertex Pharmaceuticals Incorporated · 2016